Literature DB >> 19631120

Complication and failure rates after corneal crosslinking.

Tobias Koller1, Michael Mrochen, Theo Seiler.   

Abstract

PURPOSE: To evaluate the complication rate of corneal crosslinking (CXL) for primary keratectasia and to develop recommendations for avoiding complications.
SETTING: Institut für Refraktive und Ophthalmo-Chirurgie, Zurich, Switzerland.
METHODS: In a prospective study, eyes with verified progressive keratectasia had standard CXL. Preoperative and 6- and 12-month postoperative examinations included corrected distance visual acuity (CDVA), slitlamp evaluation, applanation tonometry, and Scheimpflug imaging (Pentacam). Statistical analysis included analysis of variance and the Mann-Whitney U test to detect risk factors for complications.
RESULTS: The study evaluated 117 eyes of 99 patients; approximately 90% completed the 12-month follow-up. The complication rate (percentage of eyes losing 2 or more Snellen lines) was 2.9% (95% confidence interval, 0.6%-8.5%). The failure rate of CXL (percentage of eyes with continued progression) was 7.6%. Age older than 35 years and a preoperative CDVA better than 20/25 were identified as significant risk factors for complications. A high preoperative maximum keratometry (K) reading was a significant risk factor for failure. Sterile infiltrates were seen in 7.6% of eyes and central stromal scars, in 2.8%.
CONCLUSIONS: Results indicate that changing the inclusion criteria may significantly reduce the complications and failures of CXL. A preoperative maximum K reading less than 58.00 diopters may reduce the failure rate to less than 3%, and restricting patient age to younger than 35 years may reduce the complication rate to 1%.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19631120     DOI: 10.1016/j.jcrs.2009.03.035

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


  116 in total

1.  Complications of accelerated corneal collagen cross-linking: review of 2025 eyes.

Authors:  Semih Çakmak; Mehmet Emin Sucu; Yusuf Yildirim; Burcin Kepez Yildiz; Ahmet Kirgiz; Damla Leman Bektaşoğlu; Ahmet Demirok
Journal:  Int Ophthalmol       Date:  2020-07-26       Impact factor: 2.031

2.  The efficacy of standard versus accelerated epi-off corneal cross-linking protocols: a systematic review and sub-group analysis.

Authors:  Mohammad Miraftab; Hassan Hashemi; Mohammad Abdollahi; Shekoufeh Nikfar; Soheila Asgari
Journal:  Int Ophthalmol       Date:  2019-06-20       Impact factor: 2.031

Review 3.  [Complications of corneal cross-linking].

Authors:  T G Seiler; G Schmidinger; I Fischinger; T Koller; T Seiler
Journal:  Ophthalmologe       Date:  2013-07       Impact factor: 1.059

4.  Ultrasound-enhanced penetration of topical riboflavin into the corneal stroma.

Authors:  Ricardo Lamy; Elliot Chan; Hui Zhang; Vasant A Salgaonkar; Sam D Good; Travis C Porco; Chris J Diederich; Jay M Stewart
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-08-28       Impact factor: 4.799

Review 5.  Corneal collagen crosslinking in keratoconus and other eye disease.

Authors:  Adel Alhayek; Pei-Rong Lu
Journal:  Int J Ophthalmol       Date:  2015-04-18       Impact factor: 1.779

Review 6.  Corneal collagen cross-linking using riboflavin and ultraviolet-A irradiation: a review of clinical and experimental studies.

Authors:  Maria Gkika; Georgios Labiris; Vassilios Kozobolis
Journal:  Int Ophthalmol       Date:  2011-08-17       Impact factor: 2.031

7.  Risk factors for progression following corneal collagen crosslinking in keratoconus.

Authors:  Ayhan Sağlık; Gökçen Özcan; Ömür Uçakhan
Journal:  Int Ophthalmol       Date:  2021-05-25       Impact factor: 2.031

8.  Clinical Evaluation and Validation of the Dutch Crosslinking for Keratoconus Score.

Authors:  Robert P L Wisse; Rob W P Simons; Martijn J B van der Vossen; Marc B Muijzer; Nienke Soeters; Rudy M M A Nuijts; Daniel A Godefrooij
Journal:  JAMA Ophthalmol       Date:  2019-06-01       Impact factor: 7.389

Review 9.  New clinical pathways for keratoconus.

Authors:  D M Gore; A J Shortt; B D Allan
Journal:  Eye (Lond)       Date:  2012-12-21       Impact factor: 3.775

10.  Collagen cross-linking using riboflavin and ultraviolet-a for corneal thinning disorders: an evidence-based analysis.

Authors:  G Pron; L Ieraci; K Kaulback
Journal:  Ont Health Technol Assess Ser       Date:  2011-11-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.